DNA X, Inc. financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q3 2025.

Symbol
SONM on Nasdaq
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
31 Oct 2025

Quick Takeaways

  • SONM - DNA X, Inc. financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q3 2025.
  • Headline metric: Return On Equity -456%.

What Changed

  • Return On Equity YoY change: <span class="text-green-600">+555%</span>.
  • Most recent SEC facts end date: 28 Oct 2025.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2025-10-28) highlights Return On Equity -455.8%, Return On Assets -74.7%, and Operating Margin -54.2%.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

26.0/100

Weak Confidence high

Return On Equity

-456%

Metric score 0.0/100

Return On Assets

-75%

Metric score 0.0/100

Financial Health

Current Ratio
0.78x
Quick Ratio
0.15x
Debt to Equity
-18.24x

Strengths

Current Ratio and Revenues YoY

Watchpoints

Return On Equity, Return On Assets, and Operating Margin

Key metrics snapshot

Profitability

Metric Latest value YoY change
Return On Equity -456% +555%
Return On Assets -75% +201%
Operating Margin -54% +108%

Financial Health

Metric Latest value YoY change
Current Ratio 0.78x -26%
Quick Ratio 0.14x -67%
Debt-to-equity -18.24x -1256%

Growth

Metric Latest value YoY change
Revenues YoY 21%
NetIncomeLoss YoY -149%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 1,028,693 -79%
Common Stock, Shares, Outstanding 1,015,652 -79%
Common Stock, Value, Issued $1,000 -80%
Weighted Average Number of Shares Outstanding, Basic 984,927 +266%
Weighted Average Number of Shares Outstanding, Diluted 984,927 +266%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $59,388,000 +21%
Cost of Revenue $48,275,000 +16%
Research and Development Expense $15,230,000 -75%
Selling and Marketing Expense $13,342,000 +13%
General and Administrative Expense $13,672,000 +32%
Operating Income (Loss) $32,171,000 -152%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $33,076,000 -154%
Income Tax Expense (Benefit) $308,000 -17%
Earnings Per Share, Basic -1 +89%
Earnings Per Share, Diluted -1 +89%
Cash and Cash Equivalents, at Carrying Value $2,137,000 -76%
Accounts Receivable, after Allowance for Credit Loss, Current $3,498,000 -33%
Inventory, Net $10,986,000 -11%
Assets, Current $30,301,000 -11%
Property, Plant and Equipment, Net $140,000 -41%
Other Assets, Noncurrent $725,000 -76%
Assets $40,219,000 -18%
Accounts Payable, Current $20,408,000 +125%
Accrued Liabilities, Current $13,631,000 -41%
Liabilities, Current $38,856,000 +21%
Accrued Income Taxes, Noncurrent $1,814,000 +12%
Liabilities $40,920,000 +21%
Retained Earnings (Accumulated Deficit) $295,378,000 -13%
Stockholders' Equity Attributable to Parent $701,000 -105%
Liabilities and Equity $40,219,000 -18%
Share-based Payment Arrangement, Noncash Expense $1,738,000 +6.8%
Common Stock, Shares Authorized 100,000,000 0%
Common Stock, Shares, Issued 1,015,652 -79%
Common Stock, Par or Stated Value Per Share 0 0%
Preferred Stock, Shares Issued 0
Preferred Stock, Shares Authorized 5,000,000 0%
Unrecognized Tax Benefits $1,507,000 +16%
Additional Paid in Capital $294,676,000 +6.3%
Preferred Stock, Shares Outstanding 0
Interest Expense $339,000
Preferred Stock, Par or Stated Value Per Share 0 0%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY